SCPHARMACEUTICALS INC. Proceeds from Convertible Debt
SCPHARMACEUTICALS INC. reported Proceeds from Convertible Debt of $12.60 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2019-03-21
- SCPHARMACEUTICALS INC. proceeds from convertible debt for fiscal 2016 was $12.60M.
| Period end | Proceeds from Convertible Debt 12 month |
|---|---|
| 2016-12-31 | $12.60M 10-K · filed 2019-03-21 |